echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Round table dialogue: the next "golden decade" for high-quality development of medical and health industry

    Round table dialogue: the next "golden decade" for high-quality development of medical and health industry

    • Last Update: 2019-12-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On December 28, under the guidance of China Pharmaceutical Materials Association, the "2019 China Pharmaceutical new wisdom forum" jointly sponsored by Sina pharmaceutical and China Pharmaceutical Materials Association think tank for food and drug industry was held in Beijing The theme of this conference is "gathering wisdom and generating wisdom in a big wave" Industry experts and enterprise representatives gather to find out the variables and future of China's pharmaceutical industry In the round table dialogue of the forum, the guests and tycoons had a wonderful discussion on the theme of "the next golden decade for high-quality development of the pharmaceutical and health industry" Shao Rong, a professor from China Pharmaceutical University, presided over the dialogue Yu Mingde, honorary president of China Pharmaceutical Enterprise Management Association, Liu Xiaoping, former deputy inspector of the Department of pharmaceutical supervision of the State Food and drug administration, Pu Chuanwen, vice president of China Pharmaceutical Association and former executive vice president and deputy editor in chief of China traditional Chinese medicine newspaper, co-founder and director of Arnold pharmaceutical, participated in the discussion Yang Donghui, senior vice president The following is the real record of the round table dialogue (some of which have been deleted): Director Yu, the state is encouraging innovation and development and industrial transformation and upgrading, but in fact, quite a lot of policies are reducing the profit margin of products When we enter the process of transformation, upgrading and high-quality development, what are your suggestions? Transformation and upgrading, and high-quality development are the goals proposed by the 19th National Congress of the Communist Party of China At present, our industry is actively implementing them and all departments are supporting them But from the perspective of enterprises, there are always some special happy and frowning policies In fact, this is also a normal situation It has been for decades What Yu said made us feel confident How hard is it to move forward? Therefore, it is confirmed that "there must be a way for cars to get to the front of the mountain" We should seize the opportunity of transformation and upgrading to survive and develop Director Liu is an inspector of the State Food and Drug Administration and has considerable experience in circulation As a manager, how can we help in the next transformation and upgrading into the golden decade from the perspective of regulatory authorities? Just now, president Shao mentioned how drug supervision can help the development of the pharmaceutical industry I want to talk about it from these two aspects Drug supervision has a specific functional attribute, which is to ensure the safety of drugs However, drug supervision is not for the purpose of supervision The ultimate purpose of supervision is to improve the development level of the pharmaceutical industry as a whole, which is to ensure drug safety in a fair and just market environment Of course, at the same time, we should continue to promote the development of the pharmaceutical industry, promote the continuous innovation of the industry, so as to provide the people with the drugs needed in a timely manner and with reliable efficacy I think this is a new mission and new requirement for drug supervision in the new era Because the new drug management law has clearly proposed that drug management should protect and promote the health of citizens, which is a new requirement for drug supervision To protect the health of citizens is nothing more than to strive to prevent market risks, ensure the safety and effectiveness of drugs, and promote public health is to continuously promote the development of the pharmaceutical industry, constantly promote the innovation and development of the industry, and be able to serve the people Provide the medicine needed In the next ten years, drug supervision should not only be a good guardian of the healthy development of the industry, but also a participant and promoter of the sustainable development of the industry How can it become both a guardian and a participant and promoter? In the practice of drug supervision in the future, we should better implement the working policy of "releasing management service" which is repeatedly emphasized in the reform of our administrative system How to implement our "pipe laying service"? I want to promote the healthy, sustainable and stable development of our industry through standard empowerment and assistance according to the characteristics of drug regulation Standardization is the management of "release management service" In fact, the primary responsibility of drug supervision is to manage the counterpart, which is to maintain the normal order of the market Because the legal production and operation of the pharmaceutical industry is a bottom line, the work to be done as a supervisor is to supervise enterprises' compliance with the law, regulate market behavior, promote market fairness and justice, and punish illegal acts according to law Standardization is the only choice to promote the healthy development of the industry Empowerment refers to the "release of regulatory services", streamlining administration and delegating power, and releasing market vitality I think we can give full development energy to the development of enterprises, which is to legalize several relatively successful systems These systems will inject considerable vitality into the development of the whole industry in the future, and also play an important role in the future innovation and development Supervision should do a good job in promoting these policies and systems, and continue to empower enterprises to develop technology through system innovation, so as to give full play to the vitality of enterprises, which will promote enterprises to develop in a higher and faster direction Assistance is the service in the "release and management service" It is the duty of government departments to serve enterprises and society To reduce unnecessary red tape, we need to find more ways to continuously improve the ability of scientific and technological supervision and system supervision, so as to improve the supervision efficiency, eliminate unnecessary interference to enterprises as much as possible, improve the operation efficiency of enterprises, and enable enterprises to invest in collective life with minimum worry and fetters, so as to form a better and benign enterprise Development Just now, director Liu talked about the three principles of standardization, empowerment and assistance His personal experience is very rich, indicating two major changes: The concept of administrative law enforcement has been changed by the regulatory authorities in the process of assistance, and we all have experience in "release management service" The front-end policy will involve the whole drug life cycle and industrial chain All policies have good motives and pursue good goals, but after all, they should have ecological openness and coordination The drug law particularly emphasizes the protection and promotion of health Just now director Liu specially interpreted this aspect Today we do not simply say the next ten years of the pharmaceutical industry, but emphasize the pharmaceutical health industry Our concept of the health industry is much larger In some cases, it is not simply to say how much scale the anti-tumor medicine industry has achieved, but to make sure that patients have disease and medicine available, as well as effective and safe medicine available Can we make sure that there are fewer and fewer patients without patients? Can we extend more money to protect and promote health? There's also a lot to read In the context of protecting and promoting health, in the next decade of development, enterprises will be able to find a way to survive and develop According to President Pu's previous practice experience and interpretation of traditional Chinese medicine, in the ten years of innovation and development, in terms of the development of traditional industries, how to achieve both inheritance and promotion of innovation? The most comprehensive and authoritative topic of the inheritance, innovation and development of traditional Chinese medicine is the opinions just issued by the CPC Central Committee and the State Council on promoting the inheritance, innovation and development of traditional Chinese medicine I may learn from the spirit and opinions of the conference The inheritance, innovation and development of traditional Chinese medicine should be said to be an eternal theme of the development of traditional Chinese medicine Especially after the eighteen Party Congress, the Central Committee of CPC, with the core of general secretary Xi Jinping, attached great importance to the inheritance, innovation and development of traditional Chinese medicine This session of the National Congress of traditional Chinese medicine said that the work instructions of traditional Chinese medicine should follow the law of traditional Chinese medicine, promote the inheritance and innovation of traditional Chinese medicine, and promote the high-quality development of the cause and industry of traditional Chinese medicine According to the attention paid by the party and the government, on the 60th anniversary of the establishment of the Chinese Academy of Sciences in 2015, General Secretary Xi sent a congratulatory letter In 2016, the Chinese medicine law was approved by the National People's Congress and implemented in 2017, laying the foundation for the inheritance, innovation and legislation of Chinese medicine In 2019, the National Congress of traditional Chinese medicine was held in the name of the State Council, and opinions were issued, including the formulation of traditional Chinese Medicine Inheritance and development in the "outline of healthy China 2030 plan" issued by the national health and health conference in 2016 The party and the government attach great importance to the inheritance, innovation and development of traditional Chinese medicine, which shows that our country should achieve two centenary goals, and the urgent need of national economic and social development and people's health for the inheritance and development of traditional Chinese medicine, which also promotes the inheritance, innovation and development of traditional Chinese medicine How to inherit, innovate and develop traditional Chinese medicine? Recently, 125 aspects of this opinion have been broken down for implementation, that is, the plan for implementing the opinion All ministries and commissions are strengthening cooperation to implement it item by item The next decade will be a golden decade and a decade of great development Personal thoughts are mainly as follows: The academic inheritance, innovation and development are the innovation and development of theory first, because the theory of traditional Chinese medicine is macro compared with western medicine How to combine the macro theory and micro practice, TCM theory and clinical treatment more closely, accurately and finely to guide clinical treatment? As the first curative effect of medicine is the core, no matter what theory, clinical optimistic about the disease and cure the disease is the main Therefore, if we want to innovate and develop the theory of traditional Chinese medicine, inheritance is the basis, and then we should innovate and develop on the basis of inheritance Give full play to the original advantages of traditional Chinese medicine and play a better role in the established treatment At that time, the "51152 project" was put forward: 50 dominant diseases, 100 appropriate technologies, 100 traditional Chinese medicine varieties with unique curative effects, 50 diagnosis and treatment plans integrated with traditional Chinese and Western medicine, and 20 plans for treating and preventing diseases by health preserving and chronic disease rehabilitation of traditional Chinese medicine The combination of traditional Chinese medicine and Western medicine in the whole process of treatment of certain diseases, or in a certain stage of the treatment plan participated by traditional Chinese medicine, these plans are superior to those of pure western medicine or pure traditional Chinese medicine, which I think is also the focus of inheritance and innovation of traditional Chinese medicine Through inheritance and innovation, determine and promote TCM to show its advantages and play its role in disease prevention and treatment We will accelerate the modernization and industrialization of traditional Chinese medicine and promote the high-quality development of the cause and industry of traditional Chinese medicine I think there are five aspects: to build the brand project of traditional Chinese medicine, there are not enough hospitals to build the brand now Western medicine has been in the front in this respect, especially the provincial hospitals and national hospitals are very clear, and traditional Chinese medicine should also develop in this respect In particular, research-oriented hospitals and third-class A hospitals should develop towards large, specialized and small-scale comprehensive development, highlighting their own advantages, and at the same time, they should be able to conduct more in-depth research, promotion and innovative development in specialized fields Another is the creation of new Chinese medicine, such as artemisinin in Artemisia annua After thousands of years of Clinical Prescriptions and experience in traditional Chinese medicine, these prescriptions are carried out on human beings Now they are used for clinical experiments and laboratory experiments, and it is likely to produce some new original drugs The planting of traditional Chinese medicine also needs to create the traceability of the whole process of production and circulation of traditional Chinese medicine pieces and proprietary Chinese medicine, so as to ensure the quality of traditional Chinese medicine Because if we want to innovate traditional Chinese medicine, if the medicinal materials are not good, we can not produce high-quality drugs, and the curative effect is certainly not good We should make full use of modern advanced technology, including evidence-based medicine and other scientific and technological means that we are building, to accelerate the inheritance, innovation and development of traditional Chinese medicine Finally, the construction of the scientific and technological team of traditional Chinese medicine may not be very accurate, but as far as I know, there are now more than 20000 scientific and technological personnel of traditional Chinese medicine in China, and only 1800 scientific and technological personnel of the central unit How can such a small team bear the burden
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.